ArticleDiscover nano2026
Phyto-assisted synthesis and characterization of zinc oxide nanoparticles and zinc oxide copper composite nanoparticles using Curly Blumea (Laggera crispata) leaf extract and evaluation of their antibacterial activity.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Development of an eco-friendly process for the synthesis of Zinc Oxide Nanoparticles (ZnO-NPs) and Zinc Oxide-Copper Nanocomposites (ZnO-Cu NCs) is an important aspect in the field of nanotechnology. Curly Blumea (Laggera crispata) leaf extract was utilized to synthesize ZnO-NPs and ZnO-Cu NCs. The nanoparticles were synthesized at pH 12, temperature 80 °C, and 56 mM precursor concentration showing absorption peaks at 379 nm (ZnO-NPs) and 382 nm (ZnO-Cu NCs). The synthesized nanoparticles were characterized using XRD, FTIR, SEM, DLS, and TEM. DLS revealed hydrodynamic particle sizes of 58 nm and 31.8 nm for ZnO-NPs and ZnO-Cu NCs, respectively, while TEM showed actual sizes of approximately 20 nm (ZnO-NPs) and 30 nm (ZnO-Cu NCs). XRD confirmed a hexagonal wurtzite structure with crystallite sizes of 21.5 nm (ZnO-NPs) and 20.4 nm (ZnO-Cu NCs). SEM showed spherical and irregular agglomerated morphologies. The optical band gap energies were determined as 3.1 eV for ZnO-NPs and 2.82 eV for ZnO-Cu NCs. Gram-positive (Staphylococcus aureus and Bacillus cereus) and Gram-negative (Escherichia coli and Morganella morganii) bacteria were used to evaluate antibacterial efficacy. ZnO-NPs exhibited maximum zones of inhibition of 22 mm against S. aureus and 20 mm against B. cereus, while ZnO-Cu NCs showed enhanced activity with zones of inhibition of 23 mm against S. aureus and 22 mm against B. cereus. The results indicated that Gram-positive bacteria were more susceptible than Gram-negative bacteria to both nanomaterials. It is notable that although ZnO-Cu NCs showed smaller hydrodynamic diameter by DLS, they demonstrated superior antibacterial performance, which is attributed to their lower band gap energy and enhanced reactive oxygen species generation.Clinical Trial Number Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.